Last reviewed · How we verify
NCT05820828
Comparing Air Embolic Load in Two Venous Cannulation Methods, 40 Patients Undergoing Elective Valve Surgery.
NA trial testing Volume control in Extracorporeal Circulation; Complications in 40 participants. Completed in 28 August 2023.
28 August 2023
Quick facts
| Lead sponsor | Petronella Torild |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 40 |
| Start date | 21 April 2023 |
| Primary completion | 28 August 2023 |
| Estimated completion | 28 August 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Volume control
Conditions studied
- Extracorporeal Circulation; Complications — all drugs for Extracorporeal Circulation; Complications →
- Air Embolism — all drugs for Air Embolism →
Sponsor
Petronella Torild
Who can join
18 and older, any sex, with Extracorporeal Circulation; Complications or Air Embolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this single center prospective controlled observational and interventional trial is to investigate and compare origin of air emboli when different venous cannulation methods is used in patients undergoing cardiac surgery with extracorporeal circulation. 40 consecutive elective patients will be included in two groups, depending on the procedure requiring bicaval or cavoatrial cannulation. After assorted into respective group, patients will be block randomized (five groups consisting of eight patients each) to either intervention group (low venous reservoir volume, 200-300 mL) or control group (venous reservoir volume \> 300 mL). Primary endpoint is to investigate if the amount of air emboli passing through the oxygenator to the arterial line differs between bicaval and cavoatrial venous cannulation during extracorporeal circulation. Secondary endpoints are the relative difference in amount air emboli between the groups, if there is any correlation between the amount of air in venous line and the amount of air passing through the oxygenator to the arterial line during extracorporeal circulation, and if difference is seen on the amount of air passing through the oxygenator depending on the level of volume in the venous reservoir.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does the venous cannulation method affect gaseous embolic load to the patient during extracorporeal circulation?
Torild P, Corderfeldt Keiller A, Damén T. · · 2026 · PMID 40393695 · DOI 10.1177/02676591251344859
Verify or expand the search:
- PubMed search for NCT05820828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Extracorporeal Circulation; Complications
Currently open trials in the same condition.
- NCT06754709 — Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children · recruiting
- NCT06179771 — Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. · NA · recruiting
- NCT05669183 — Hemodynamic Comparison of Peripheral and Central VA ECMO. · recruiting
- NCT06095518 — DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study · recruiting
- NCT05487612 — MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05820828 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Petronella Torild
- Last refreshed: 3 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05820828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing